C320-0202 Screening compound: 3-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-N~1~-{[1-(3-methylbenzyl)-4-piperidyl]methyl}propanamide

C320-0202 Screening compound: 3-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-N~1~-{[1-(3-methylbenzyl)-4-piperidyl]methyl}propanamide
C320-0202 Screening compound: 3-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-N~1~-{[1-(3-methylbenzyl)-4-piperidyl]methyl}propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C320-0202
3-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-N~1~-{[1-(3-methylbenzyl)-4-piperidyl]methyl}propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C320-0202

Molecular Formula

C26H32N4O3 (C26 H32 N4 O3)

Compound Name

3-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-N~1~-{[1-(3-methylbenzyl)-4-piperidyl]methyl}propanamide

IUPAC name

n/a

SMILES

Cc1cccc(CN2CCC(CNC(CCc3nc(-c(cc4)ccc4OC)no3)=O)CC2)c1

InChI

InChI=1S/C26H32N4O3/c1-19-4-3-5-21(16-19)18-30-14-12-20(13-15-30)17-27-24(31)10-11-25-28-26(29-33-25)22-6-8-23(32-2)9-7-22/h3-9,16,20H,10-15,17-18H2,1-2H3,(H,27,31)

InChI Key

APHACUBILSTVKL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14748353

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

448.57

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.560

Distribution Coefficient, logD

2.068

Water Solubility, LogSw

-4.36

Polar Surface Area

67.058

Acid Dissociation Constant (pKa)

14.59

Base Dissociation Constant (pKb)

9.89

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

42.30

C320-0202 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Anticancer Library (62698 compounds)

CNS targets activity set (6557 compounds)

GPCR Targeted Library (31838 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • GPCR
  • Proteases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with C320-0202 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C320-0202?
Check Price and Availability of C320-0202, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C320-0202 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C320-0202
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C320-0202
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C320-0202 available by request